Open AccessP679 Risk factors for disease relapse after stepping down from combination to anti-TNF monotherapy in children with IBD
Author(s) -
Anat YerushalmyFeler,
Shlomi Cohen
Publication year - 2018
Publication title -
journal of crohn s and colitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.277
H-Index - 80
eISSN - 1876-4479
pISSN - 1873-9946
DOI - 10.1093/ecco-jcc/jjx180.806
Subject(s) - medicine , exacerbation , infliximab , combination therapy , disease , faecal calprotectin , risk factor , inflammatory bowel disease , calprotectin
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom